Thanks to the support of the MAPS Health Equity Fund, we are honored to offer a number of full ($5,000) and partial ($2,500) scholarships for tuition fees for the 2022 training program.
The MAPS Health Equity Scholarship is part of MAPS and MAPS PBC’s larger commitment to increasing inclusion and equity in our programs and advancing the initiatives outlined by the MAPS Health Equity Fund.
By awarding funds through the MAPS Health Equity Scholarship, the MDMA Therapy Training Program hopes to achieve the following in 2022:
  • Create a more accessible training program to ensure that the network of MDMA-Assisted Therapy Practitioners is vast and able to support diverse communities suffering from a spectrum of trauma.
  • Increase the number of MAPS-Certified MDMA-Assisted Therapy Practitioners who identify as Black, Indigenous, and people of color.
  • Train and learn from more therapy practitioners who live and work in historically marginalized communities.
  • Foster connection and validate unique experiences of trauma in marginalized communities.


The MAPS Health Equity Scholarship will be granting funds to qualified practitioners under 4 main criteria

  • Black, Indigenous, and all practitioners of color
  • Trans and non-binary practitioners
  • LGBTQIA+ practitioners
  • Practitioners from refugee communities

Applicants who demonstrate financial need will be given priority in the scholarship selection process.


In order to be considered for a MAPS Health Equity Scholarship, applicants must:

Scholarship applications can only be considered for applicants who have a training program application on file.


Applications will be reviewed as they are received.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Contact Us

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

Therapy Training


MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Stay Up-to-Date about MDMA Therapy Training

You have Successfully Subscribed!